{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90415",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.",
      "recall_number": "D-1150-2022",
      "product_description": "Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16",
      "product_quantity": "3,216 bottles",
      "reason_for_recall": "Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.",
      "recall_initiation_date": "20220610",
      "center_classification_date": "20220615",
      "termination_date": "20230208",
      "report_date": "20220622",
      "code_info": "Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22",
      "more_code_info": ""
    }
  ]
}